| Company Name: |
Yichang Zhongyitai Trading Co., Ltd.
|
| Tel: |
0717-6449896 13886658719 |
| Email: |
root@zhongyitai.com |
| Products Intro: |
Product Name:C6 NBD-Sphingosine, beta-D-lactosylsphingosine
CAS:474943-04-9
Purity:98+% Package:50ug
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Email: |
support@alfa-chemistry.com |
| Products Intro: |
Product Name:C6 NBD-Sphingosine, beta-D-lactosylsphingosine
CAS:474943-04-9
Purity:98%+ Package:1g;10g;100g;1KG;5KG
|
|
| | C6 NBD-Sphingosine, beta-D-lactosyl Basic information |
| Product Name: | C6 NBD-Sphingosine, beta-D-lactosyl | | Synonyms: | N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)aMino]hexanoyl]-D-lactosyl-1-1'-sphingosine;N-[6-[(7-NITRO-2-1,3-BENZOXADIAZOL-4-YL)AMINO]HEXANOYL]-D-LACTOSYL-1-1'-SPHINGOSINE;C6-NBD LACTOSYL CERAMIDE;C6 NBD Lactosylceramide (d18:1/6:0);Hexanamide, N-[(1S,2R,3E)-1-[[(4-O-β-D-galactopyranosyl-β-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-6-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-;C6 NBD-Sphingosine, beta-D-lactosylsphingosine;N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-lactosyl-β1-1'-sphingosine | | CAS: | 474943-04-9 | | MF: | C42H69N5O16 | | MW: | 900.02 | | EINECS: | | | Product Categories: | | | Mol File: | 474943-04-9.mol |  |
| | C6 NBD-Sphingosine, beta-D-lactosyl Chemical Properties |
| solubility | Chloroform:Methanol (2:1): soluble | | form | A solid |
| | C6 NBD-Sphingosine, beta-D-lactosyl Usage And Synthesis |
| Description | C6 NBD Lactosylceramide (d18:1/6:0) is a biologically active derivative of lactosylceramides (d18:1/acyl mixture) that is tagged with a fluorescent C-6 nitrobenzoxadiazole (C-6 NBD; ) group.1 C6 NBD Lactosylceramide (d18:1/6:0) has been used to study the effects of P-glycoprotein inhibition in lactosylceramide metabolism-based therapeutics for the treatment of cancer. As this product is derived from a natural source, there may be variations in the sphingoid backbone. | | References | 1. Morad, S.A., Davis, T.S., MacDougall, M.R., et al. Role of P-glycoprotein inhibitors in ceramide-based therapeutics for treatment of cancer Biochem. Pharmacol. 130,21-33(2017). |
| | C6 NBD-Sphingosine, beta-D-lactosyl Preparation Products And Raw materials |
|